Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed
Publication
, Journal Article
Marcom, PK; Verrier, CS
Published in: ONCOLOGY-NEW YORK
December 1, 2006
Duke Scholars
Published In
ONCOLOGY-NEW YORK
ISSN
0890-9091
Publication Date
December 1, 2006
Volume
20
Issue
14
Start / End Page
1775 / 1776
Publisher
P R R INC
Citation
APA
Chicago
ICMJE
MLA
NLM
Marcom, P. K., & Verrier, C. S. (2006). Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed. ONCOLOGY-NEW YORK, 20(14), 1775–1776.
Marcom, P Kelly, and Carmel S. Verrier. “Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed.” ONCOLOGY-NEW YORK 20, no. 14 (December 1, 2006): 1775–76.
Marcom PK, Verrier CS. Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed. ONCOLOGY-NEW YORK. 2006 Dec 1;20(14):1775–6.
Marcom, P. Kelly, and Carmel S. Verrier. “Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed.” ONCOLOGY-NEW YORK, vol. 20, no. 14, P R R INC, Dec. 2006, pp. 1775–76.
Marcom PK, Verrier CS. Trastuzumab and beyond: New possibilities for the treatment of HER2-positive breast cancer - The Morris/Carey article reviewed. ONCOLOGY-NEW YORK. P R R INC; 2006 Dec 1;20(14):1775–1776.
Published In
ONCOLOGY-NEW YORK
ISSN
0890-9091
Publication Date
December 1, 2006
Volume
20
Issue
14
Start / End Page
1775 / 1776
Publisher
P R R INC